Healthcare - Biotechnology - NASDAQ - US
$ 19.04
-5.74 %
$ 4.5 B
Market Cap
70.52
P/E
INCOME STATEMENT
258 M
REVENUE
21.6 M
OPERATING INCOME
-28.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
ADMA Biologics, Inc.
| Revenue | 258 M |
| Cost Of Revenue | 170 M |
| Gross Profit | 88.2 M |
| Operating Expenses | 66.6 M |
| Operating Income | 21.6 M |
| Other Expenses | 49.9 M |
| Net Income | -28.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | Jun-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||
| Revenue | 258.2 | 154.1 | 80.9 | 42.2 | 29.3 | 17.0 | 22.8 | 10.7 | 7.2 | 5.9 | 3.1 | 1.1 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||||||||||
| Cost Of Revenue | 170.0 | 118.8 | 79.8 | 61.3 | 39.5 | 42.2 | 29.2 | 6.4 | 4.3 | 3.7 | 2.0 | 0.7 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 88.2 | 35.3 | 1.2 | (19.1) | (10.2) | (25.2) | (6.4) | 4.3 | 2.9 | 2.2 | 1.0 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||||||||||
| Operating Expenses | 66.6 | 74.6 | 59.5 | 45.8 | 31.3 | 35.1 | 32.1 | 21.6 | 18.4 | 18.2 | 16.1 | 8.4 | 26.5 K | 20.5 K | (20.0) | 24.9 | 29.7 |
| Selling, General and Administrative Expenses | 59.0 | 52.5 | 42.9 | 35.1 | 25.9 | 22.5 | 18.1 | 8.5 | 6.7 | 4.8 | 4.4 | 3.1 | 26.5 K | 20.5 K | 0 | 0 | 24 K |
| Research and Development Expenses | 3.3 | 3.6 | 3.6 | 5.9 | 2.3 | 3.9 | 6.2 | 7.7 | 7.0 | 9.5 | 9.3 | 3.5 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 21.6 | (39.4) | (58.4) | (64.9) | (41.4) | (60.3) | (39.3) | (17.3) | (15.5) | (16.0) | (15.0) | (7.9) | 26.5 K | 20.5 K | (20.0) | (24.9) | (29.7) |
| PRE-TAX INCOME | |||||||||||||||||
| Interest Income Expense | 25.0 | 19.3 | 13.1 | 12.0 | 9.0 | 5.5 | 3.3 | 2.2 | 1.8 | 1.3 | 0.6 | 30.7 K | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (49.9) | (26.8) | (13.5) | (10.8) | (6.9) | (5.5) | (4.4) | (2.2) | (2.5) | (1.3) | (0.5) | 9.76 K | (6.2) | (5.9) | 0 | 0 | 0 |
| Pre-Tax Income | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) | (18.0) | (17.4) | (15.5) | (7.9) | 26.5 K | 20.5 K | (20.0) | (24.9) | (29.7) |
| NET INCOME | |||||||||||||||||
| Tax Provision | 0 | 19.3 | 12.8 | 11.9 | 8.8 | 5.5 | 4.4 | 2.2 | 2.5 | (0.6) | 0.5 | (0.6) | 4 | 4 | 0 | 0 | 0 |
| Net Income | (28.2) | (85.2) | (84.5) | (87.6) | (57.0) | (65.7) | (43.8) | (19.5) | (18.0) | (16.8) | (15.5) | (7.3) | 26.5 K | 20.5 K | (20.0) | (24.9) | (29.7) |
| EPS | 0.13 | 0.43 | 0.61 | 1.02 | 1.05 | 1.45 | 1.91 | 1.61 | 1.73 | 1.81 | 2.38 | 1.39 | 0.0106 | 0.0082 | 8 | 9.96 | 11.9 |